News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,935 Results
Type
Article (88962)
Company Profile (555)
Press Release (796399)
Multimedia
Podcasts (247)
Webinars (36)
Section
Business (267073)
Career Advice (4166)
Deals (40031)
Drug Delivery (181)
Drug Development (91793)
Employer Resources (208)
FDA (18607)
Job Trends (17499)
News (398916)
Policy (40024)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3061)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (245)
Alzheimer's disease (2046)
Antibody-drug conjugate (ADC) (595)
Approvals (19008)
Artificial intelligence (924)
ASCO (345)
Autoimmune disease (388)
Automation (70)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (262)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (86)
Breast cancer (865)
Cancer (6843)
Cardiovascular disease (576)
Career advice (3603)
Career pathing (54)
CAR-T (396)
CDC (77)
Celiac Disease (3)
Cell therapy (1112)
Cervical cancer (59)
Clinical research (79442)
Collaboration (2481)
Commercialization (1)
Company closure (8)
Compensation (1598)
Complete response letters (116)
COVID-19 (3046)
CRISPR (130)
C-suite (1375)
Cystic fibrosis (170)
Data (9062)
Decentralized trials (3)
Denatured (94)
Depression (205)
Dermatology (105)
Diabetes (733)
Diagnostics (7660)
Digital health (74)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (468)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (335)
Earnings (102601)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139053)
Executive appointments (1236)
FDA (22911)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2032)
Gene editing (285)
Generative AI (93)
Gene therapy (877)
GLP-1 (1304)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21277)
Hematology (198)
HIV (102)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (120)
Immunology and inflammation (369)
Immuno-oncology (122)
Indications (227)
Infectious disease (3459)
Inflammatory bowel disease (247)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (337)
Interviews (823)
IPO (18017)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (128)
Layoffs (697)
Leadership (55)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (905)
Lymphoma (493)
Machine learning (70)
Management (68)
Manufacturing (1315)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15322)
Medtech (15520)
Mergers & acquisitions (23380)
Metabolic disorders (1888)
mRNA (282)
Multiple sclerosis (214)
NASH (24)
Neurodegenerative disease (546)
Neuropsychiatric disorders (133)
Neuroscience (3879)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5148)
Now hiring (84)
Obesity (894)
Opinion (383)
Ovarian cancer (253)
Pain (295)
Pancreatic cancer (376)
Parkinson's disease (432)
Partnered (43)
Patents (697)
Patient recruitment (836)
Peanut (72)
People (68234)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24544)
Phase 2 (34506)
Phase 3 (25947)
Pipeline (10503)
Policy (406)
Postmarket research (3561)
Preclinical (11012)
Press Release (72)
Prostate cancer (361)
Psychedelics (77)
Radiopharmaceuticals (382)
Rare diseases (1347)
Real estate (7463)
Recruiting (82)
Regulatory (30742)
Reports (78)
Research institute (2777)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (252)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (150)
Vaccines (1339)
Venture capital (143)
Weight loss (608)
Women's health (148)
Worklife (25)
Date
Today (125)
Last 7 days (476)
Last 30 days (2168)
Last 365 days (33380)
2026 (18560)
2025 (33215)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1298)
Alabama (103)
Alaska (7)
Arizona (411)
Arkansas (16)
Asia (52478)
Australia (9221)
California (14775)
Canada (4153)
China (1674)
Colorado (636)
Connecticut (652)
Delaware (454)
Europe (121005)
Florida (2223)
Georgia (480)
Hawaii (4)
Idaho (70)
Illinois (1293)
India (110)
Indiana (677)
Iowa (25)
Japan (631)
Kansas (144)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1771)
Massachusetts (10811)
Michigan (428)
Minnesota (821)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (159)
New Hampshire (92)
New Jersey (3915)
New Mexico (35)
New York (3904)
North Carolina (1958)
North Dakota (11)
Northern California (7383)
Ohio (461)
Oklahoma (28)
Oregon (46)
Pennsylvania (2893)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (92)
South Dakota (2)
Southern California (5832)
Tennessee (241)
Texas (2399)
United States (52756)
Utah (443)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1196)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 885,935 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GemPharmatech and Humlab Global Sign Strategic Agreement to Deliver Humanized Mouse Models for Improved Clinical Translation
July 15, 2026
·
1 min read
Lung cancer
Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytruda
The Phase 3 results are the first direct proof-of-concept for an ADC replacing platinum-based chemo in a first-line standard-of-care regimen for non-small cell lung cancer, according to Leerink Partners. The readout also represents the second late-stage win for the Merck and Kelun-Biotech asset, called sac-TMT.
July 15, 2026
·
2 min read
·
Michael Gibney
Antibody-drug conjugate
Pfizer scraps Seagen-developed ADC for solid tumors
Just weeks after Pfizer’s Seagen-acquired antibody-drug conjugate sigvotatug vedotin failed a Phase 3 non-small cell lung cancer study, the big pharma has quietly culled another program being developed by the ADC specialist.
July 15, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
ORASIS PHARMACEUTICALS ANNOUNCES AUSTRALIA SUBMISSION OF A NEW DRUG APPLICATION FOR BESKA FOR THE TREATMENT OF PRESBYOPIA
July 15, 2026
·
6 min read
Press Releases
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
July 15, 2026
·
16 min read
Press Releases
Orthofix to Report Second Quarter 2026 Financial Results
July 15, 2026
·
1 min read
Press Releases
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
July 15, 2026
·
2 min read
Press Releases
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
July 15, 2026
·
19 min read
Press Releases
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS
July 15, 2026
·
5 min read
Press Releases
Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch
July 15, 2026
·
6 min read
1 of 88,594
Next
